Wed Jan 5, 2022 – 10:10 pm EST
(LifeSiteNews) — A massive pre-print study released in December showed that low preventive dosages of ivermectin, taken every two weeks, reduced mortality by 68%. This apparent good news was not welcomed by Twitter, which immediately moved to censor the paper, slapping it with a “Misleading” warning label without explanation.
The study, involving 220,517 subjects, was conducted in the Brazilian city of Itajaí, where all of the citizens were invited to participate. Its objective was to measure the impact of regular ivermectin use against COVID-19 infection, severe symptoms, and mortality rates in a real-world setting.
After the collection of each subject’s baseline personal and medical information, ivermectin was offered as an optional preventive treatment to each person, consisting of light dosages of 0.2 mg per kilogram of body weight for two consecutive days every 15 days. 133,051 (60.3%) participants accepted the treatments and 87,466 (39.7%) declined, providing the study with exceedingly large sample sizes for both the treatment and control groups.
As a result, the study reports that the “regular use of ivermectin led to a 68% reduction in COVID-19 mortality,” which following adjustments for “residual variables,” reached 70%. Further, the hospitalization rate of the treatment group was 56% lower, and after similar adjustments, 67%.
“These results indicate that medical-based optional prescription, citywide covered ivermectin can have a positive impact in the healthcare system,”
The remainder of this article is available in its entirety at LifeSite News
The views expressed in this news alert by the author do not directly represent that of The Official Street Preachers or its editors
